Back    Zoom +    Zoom -
<Hindsight>Latest TPs/ Opinions for HKEX (00388.HK) Post-Quarterly Results
Recommend
23
Positive
29
Negative
10
Broker│ Rating│ TP
Goldman Sachs│ Buy│$544→$562
JPMorgan│ Overweight│$530
Citi│ Buy│$510→$515
Morgan Stanley│ Overweight│$508
CICC│ Outperform│$500
UBS│ Neutral│$485→$471

Broker│ Opinion
Goldman Sachs│ Multiple factors drove further valuation re-rating; EPS forecasts and target price were raised
JPMorgan│ Results beat expectations, with actual trend remaining
Citi│2025/ 2026 EPS forecasts were lifted by 1-2%
Morgan Stanley│ Quarterly results were strong, benefiting from robust core revenue growth, in line with forecasts
CICC│ Focus on capital re-allocation opportunities amid robust fundamentals and stagnant valuations
UBS│4Q25 average daily turnover is expected to be impacted by seasonality (southbound trading suspension during National Day Golden Week holiday)

Related NewsG Sachs Lists H-shr Buy Stocks upon ERLI (Table)

AAStocks Financial News
Website: www.aastocks.com